IPO Monitor
Subscribe Login Login About Us Contact Us Help
Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]


Tilray IPO is 'validation' for pot companies, CEO says

First cannabis IPO on Nasdaq scores $1.4 billion valuation, shares soar 76% since debut Thursday. Tilray Inc. (TLRY) landed a valuation topping $1 billion and became the first cannabis company to go public on the Nasdaq exchange Thursday, then received even more validation when shares popped more than 76% over Thursday and Friday. The hot IPO was just another first for a cannabis company that has made bold, global bets on an industry that for decades was run by drug cartels and Northern...
[ Fidelity at 2018-07-20 14:56:49 ]


BRIEF-Blank Check Company Tenzing Acquisition Corp Files For IPO Of Up To $50 Mln

Tenzing Acquisition Corp: * BLANK CHECK COMPANY TENZING ACQUISITION CORP FILES FOR IPO OF UP TO $50 MILLION – SEC FILING Source text:
[ Fidelity at 2018-07-20 13:53:32 ]


BRIEF-Megalith Financial Acquisition Corp, A Blank Check Co, Files For IPO Of Up To $150 Mln

* MEGALITH FINANCIAL ACQUISITION CORP, A BLANK CHECK COMPANY, FILES FOR IPO OF UP TO $150 MILLION – SEC FILING Source text:
[ Fidelity at 2018-07-20 13:53:15 ]


Aramco's potential SABIC deal to impact IPO timing - CEO on Arabiya TV

Saudi Aramco's potential acquisition of a stake in Saudi petrochemicals maker SABIC would affect the time frame of its own planned initial public offering, Aramco's chief executive Amin Nasser said in a television interview on Friday.
[ Fidelity at 2018-07-20 13:09:46 ]


BRIEF-Safe-T Group Ltd Sees U.S. IPO Of 1 Million American Depositary Shares Priced Between $9.50 And $10.50 Per ADS

Safe-T Group Ltd: * SAFE-T GROUP LTD SEES U.S. IPO OF 1 MILLION AMERICAN DEPOSITARY SHARES PRICED BETWEEN $9.50 AND $10.50 PER ADS - SEC FILING. * SAFE-T GROUP LTD - HAVE APPLIED TO LIST THE ADSS ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL “SFET” Source text - Further company coverage:
[ Fidelity at 2018-07-20 11:25:11 ]


Cushman & Wakefield's IPO: Here are 5 things to know

The company is saddled with debt and will pay no dividends' for the foreseeable future'. Cushman& Wakefield, a giant real-estate services firm, is expected to price its initial public offering on Monday, and seeks to raise about $750 million, The Wall Street Journal reported Friday, citing sources. The company filed for an IPO in June, citing its past record of success, broad footprint, and the "growing" industry in which it operates.
[ Fidelity at 2018-07-20 06:36:32 ]


Arlo IPO: 5 things to know about the Netgear security-camera spinoff

Device sales account for nearly all of Arlo's revenue, which hasn't been a good approach for young hardware companies. For hardware companies these days, success following an initial public offering depends on an ability to convince investors that the business is about more than just the sale of a physical product. Arlo Technologies Inc. is the next company that will have to make that case to Wall Street.
[ Fidelity at 2018-07-20 05:04:22 ]


BRIEF-Amalgamated Bank Plans Initial Public Offering

Amalgamated Bank: * AMALGAMATED BANK PLANS INITIAL PUBLIC OFFERING. * AMALGAMATED BANK - APPLIED TO LIST ITS CLASS A COMMON STOCK ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOL "AMAL" * AMALGAMATED BANK SAYS FILED REGISTRATION STATEMENT ON FORM 10 WITH FEDERAL DEPOSIT INSURANCE FOR PROPOSED LISTING OF AMALGAMATED BANK CLASS A COMMON STOCK Source text for Eikon: Further company coverage:
[ Fidelity at 2018-07-20 04:04:03 ]


BRIEF-Molino Cañuelas S.A.C.I.F.I.A. Files To Withdraw U.S. IPO Plans

Molino Cañuelas S.A.C.I.F.I.A.: * MOLINO CAÑUELAS S.A.C.I.F.I.A. FILES TO WITHDRAW U.S. IPO PLANS - SEC FILING. * MOLINO CAÑUELAS S.A.C.I.F.I.A. SAYS IT HAD FILED FOR U.S. IPO OF UP TO $100 MILLION IN SEPTEMBER 2017 Source text:
[ Fidelity at 2018-07-20 03:16:33 ]


BRIEF-Replimune Announces Pricing Of Initial Public Offering

Replimune Group Inc(REPL): * REPLIMUNE ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 6.70 MILLION COMMON SHARES PRICED AT $15.00PER SHARE Source text for Eikon: Further company coverage:
[ Fidelity at 2018-07-19 17:56:15 ]


Replimune Announces Pricing of Initial Public Offering


[ GlobeNewswire at 2018-07-19 17:50:00 ]


Provention Bio Closes Upsized IPO, Generating Almost $64 Million in Gross Proceeds

Provention Bio late Thursday said it has closed on its upsized $63.9 million initial public offering of stock, selling just under 16 million shares - up from its original plan of offering a maximum of 15 million shares - at $4 apiece, matching its expected IPO price.
[ Fidelity at 2018-07-19 13:39:21 ]


Canadian cannabis company Tilray's shares soar 22% in trading debut

Canadian cannabis company Tilray Inc.' s shares surged 22% in their trading debut Thursday, after the company priced its initial public offering at $17, above its $14 to $16 price range. The company raised $153 million in the deal, by selling 9 million shares in the U.S. and another 2.476 million shares classified as subordinate voting shares in Canada and other countries at 22.45 Canadian dollars Tilray, a federally-licensed marijuana cultivator, processor and distributor,...
[ Fidelity at 2018-07-19 12:17:56 ]


Tilray IPO is 'validation' for pot companies, CEO says

First cannabis IPO on Nasdaq scores $1.4 billion valuation, shares soar 30% in debut. Tilray Inc. landed a valuation topping $1 billion and became the first cannabis company to go public on the Nasdaq exchange Thursday, then received even more validation when shares popped more than 30% in initial trades. The hot IPO was just another first for a cannabis company that has made bold, global bets on an industry that for decades was run by drug cartels and Northern California growers...
[ Fidelity at 2018-07-19 12:17:55 ]


Biotech Allakos shares surge more than 70% in trading debut

Biotech Allakos Inc.' s shares surged more than 70% in their trading debut Thursday, after the company priced its initial public offering at $18 a share, above its $15 to $17 price range. The clinical-stage company, which focuses on developing antibodies for the treatment of eosinophil and mast cell related diseases, sold 7.1 million shares to raise $127.8 million. Shares are trading on Nasdaq, under the ticker symbol "ALLK."
[ Fidelity at 2018-07-19 10:50:58 ]


Tilray IPO is 'validation' for pot companies, CEO says

First cannabis IPO on Nasdaq scores $1.4 billion valuation, shares soar 30% in debut. Tiilray Inc. landed a valuation topping $1 billion and became the first cannabis company to go public on the Nasdaq exchange Thursday, then received even more validation when shares popped more than 30% in initial trades. The hot IPO was just another first for a cannabis company that has made bold, global bets on an industry that for decades was run by drug cartels and Northern California growers...
[ Fidelity at 2018-07-19 10:29:18 ]


Tilray, First Cannabis Company Listed on Nasdaq, Jumps Almost 30% on IPO Day

Shares of Tilray (TLRY), the first pure-play cannabis company to be listed on that Nasdaq, jumped on its opening day on the exchange, beating Wall Street expectations. The company in a filing with the Securities & Exchange Commission earlier this week had said that it would offer shares between $14 and $16, but instead they were priced at $17.
[ Fidelity at 2018-07-19 10:09:42 ]


Constellation Pharmaceuticals shares slide 25% in trading debut

Constellation Pharmaceuticals Inc.(CNST) shares slid 25% in their trading debut Thursday, after the company priced its initial public offering in the middle of its range and reduced the size of the deal by 25%. The company is developing cancer therapies that modulate abnormal genes. It had a net loss of $53.8 million in 2017, after a loss of$ 49.5 million in 2016, and had no revenue, according to its prospectus.
[ Fidelity at 2018-07-19 08:47:12 ]


Allakos Prices IPO At $18/Share

Biotechnology company Allakos (ALLK), on early Thursday, priced the initial public offering of its 7,133,333 shares at $18 per share for total proceeds of about $128.4 million. Allakos (ALLK) gave the underwriters a 30-day option to purchase up to an additional 1,069,999 common shares at the same offering price. Price: 18.00, Change: +18.00, Percent Change: 0.00. MT Newswires does not provide investment advice.
[ Fidelity at 2018-07-19 08:38:21 ]


Canadian cannabis company Tilray's shares soar 22% in trading debut

Canadian cannabis company Tilray Inc.' s shares surged 22% in their trading debut Thursday, after the company priced its initial public offering at $17, above its $14 to $16 price range. The company raised $153 million in the deal, by selling 9 million shares in the U.S. and another 2.476 million shares classified as subordinate voting shares in Canada and other countries at 22.45 Canadian dollars Tilray, a federally-licensed marijuana cultivator, processor and distributor,...
[ Fidelity at 2018-07-19 07:42:35 ]


More IPO News >>    

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2018 IPO Monitor. All rights reserved